Mayo Clinic: Institutional Perspectives in Neurology, Chaired by Brian G. Weinshenker, MD

NeurologyLive^® State of the Science events are short meetings designed to educate neurologists and APPs on the clinical benefits associated with the new science driving new thinking. Our renowned faculty focuses on the most relevant topics to ultimately improve patient care.

TOPICS INCLUDE:

• Atypical Forms and Presentations of Demyelinating Disease – W. Oliver Tobin, MBBCh, BAO, PhD
• Newly Approved FDA S1P Oral Medications for Multiple Sclerosis – Jessica Stulc, MD, MPH
• Recently FDA Approved Injectable (B-cell Depleting) Medications for MS – Orhun H. Kantarci, MD
• Infections on MS Disease Modifying Treatments – Brian G. Weinshenker, MD